ANU microscopes


The Oxford Parkinson's Disease Centre offers attractive opportunities to work with leading researchers in advancing the understanding of Parkinson's.

To discuss research opportunities with OPDC email

Neuronal Cell Biologists

Closing date for applications: Thursday, April 19, 2018

For more details on the roles, including how to apply, please click on the links above.

Applications are invited for a Research Assistant neuronal cell biologist, two postdoctoral neuronal cell biologists and a postdoctoral neuronal cell biologist to manage the team working on a collaborative research project between the Oxford Parkinson's Disease Centre (OPDC) and the Oxford Drug Discovery Institute (ODDI) funded by FORMA Therapeutics to perform target and drug discovery for Parkinson’s in the ubiquitination system.

This is an exciting opportunity to work at the interface between academic research and pharmaceutical target and drug discovery to contribute to the discovery of novel therapeutics for Parkinson’s focused on the ubiquitination pathway. This project aims to better understand the molecular mechanisms around the ubiquitination pathway in Parkinson’s and develop new therapies by working with induced pluripotent stem cell (iPSC) lines and dopamine neurons generated from people with Parkinson’s, rodent primary neuronal cultures and cell lines.

The posts are funded for 2 years in the first instance and will be based in the Laboratory of Molecular Neurodegeneration. Informal enquiries may be directed to Professor Richard Wade-Martins (


Postdoctoral Neuroscientist

Closing date for applications: Friday, May 4, 2018 For more details on the roles, including how to apply, please click here.

We are seeking a Postdoctoral Neuroscientist to develop, execute, analyse and report on state-of-the-art electrophysiological, anatomical and behavioural experiments in rodents, as part of a scientific project designed to elucidate the function/dysfunction of midbrain dopaminergic neurons in novel models of Parkinson’s.

In addition to having a PhD, MD or equivalent qualification in a relevant discipline, candidates should have a promising track record of original research in their particular field of neuroscience. Candidates are also expected to have technical expertise in electrophysiology (either in vitro or in vivo), and to provide evidence of creative and critical thinking as applied to the delivery of a focused programme of research. Experience of neuroanatomical methods and of implementing rodent behavioural experiments is also desirable.

The postholder will work in the two groups respectively led by Professor Peter Magill and Dr Paul Dodson, and will be based at the MRC Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford.